Effect of stocking rate, grazing system, and fenbendazole treatment on subclinical parasitism in dairy heifers

Average daily weight and fecal parasitic egg count were compared among sixty 7- to 15-month-old Holstein heifers randomly assigned to 8 groups. The following variables were examined: grazing system (continuous vs rotational), stocking rate (3.5 vs 5 heifers/ha), and treatment [control vs dosing with a 10% suspension of fenbendazole (5 mg/kg of body weight) given orally 21 and 49 days after heifers were placed on pasture]. Two heifers from each group were euthanatized 4 weeks after the completion of the 148-day trial to determine the number of parasitic larvae and adults in the abomasum and intestine. Heifers treated with fenbendazole had significantly (P less than 0.001) fewer fecal ova and fewer inhibited abomasal larvae (P less than 0.05) than did controls. Mean total weight gain and mean daily rate of gain of fenbendazole-dosed heifers were significantly (P less than 0.01) increased by 17.3 kg or 0.12 kg/day, respectively, compared with those of nontreated heifers. Seemingly, stocking rate and grazing systems had no marked effect on subclinical parasitism in heifers.     

Inconsistencies in the absorptive capacities of Schirmer tear test strips

The absorptive capacities of 4 commercially available tear test strips were determined and compared with 5-mm X 40-mm strips of #41 filter paper. Significant differences in the absorption of water over a given time interval were found in 3 of the groups tested. Major inconsistencies were found only within 1 lot of tear test strips from a single manufacturer. Tear test strips from this lot consisted of 2 distinct populations that were distinguishable by transillumination. Strips with widely spaced horizontal lines had the same absorptive capacity as the filter paper, whereas those with fine lines consistently absorbed less water. The clinical importance of this discrepancy was verified by comparing measurements of tear production in 6 normal dogs.     

Hypercalcaemia associated with angiostrongylus vasorum in three dogs

Hypercalcaemia was identified in three dogs that presented primarily for evaluation of respiratory disease. Angiostrongylosis was diagnosed in all three cases and both the respiratory signs and the hypercalcaemia resolved with treatment. Infection with Angiostrongylus vasorum is known to lead to formation of pulmonary granulomata. Granulomatous disease in humans may lead to hypercalcaemia secondary to increased unregulated production of 1,25-dihydroxycholecalciferol by activated macrophages in the granulomata. In one of the three dogs, 1,25-dihydroxycholecalciferol was measured and found to be increased, providing supportive evidence for a similar mechanism in dogs. To the authors' knowledge, hypercalcaemia has not previously been reported in association with angiostrongylosis in dogs. Since prolonged untreated hypercalcaemia may lead to permanent impairment of renal function, dogs with angiostrongylosis should be evaluated for the presence of hypercalcaemia.     

Evaluation of a point-of-care immunodot assay for predicting results of allergen-specific intradermal and immunoglobulin E serological tests

Immunotherapy to prevent recurrence of clinical signs of atopic dermatitis (AD) is based on intradermal or serological tests that assist in identifying allergen-specific immunoglobulin E hypersensitivities. Unfortunately, the results of such tests can be negatively influenced by several factors, which include the age of the patients, the season of testing and the administration of anti-allergic drugs. Screening to predict when these expensive tests will be useful would benefit owners of dogs with AD. The objectives of this study were to determine whether a point-of-care allergen-specific immunodot assay (Allercept E-Screen, Heska Corp., Ft Collins, CO, USA) could predict results of either intradermal or Allercept full panel serological tests in atopic dogs. Thirty dogs living in the south-eastern USA were diagnosed with AD in accordance with current standards. Allergen-specific intradermal, serological and E-Screen tests were performed in all subjects. For flea, house dust mite and pollen allergens altogether, results of the E-Screen assay agreed with those of intradermal and serological tests in 26/30 dogs (87%) and 25/30 dogs (83%), respectively. In this group of dogs, the probabilities of obtaining intradermal or serological tests positive for these allergens were 70 and 67%, respectively. If either skin or serum tests were performed only in dogs with positive E-Screen tests, the probability of obtaining positive results would be increased from 70 to 95% and from 67 to 90%, respectively. In this population of dogs with AD, results of the E-Screen point-of-care immunodot assay was found to often agree with those of allergen-specific intradermal or Allercept tests for selected allergen groups.     

Parasitemia in an immunocompetent horse experimentally challenged with Sarcocystis neurona sporocysts

Equine protozoal myeloencephalitis (EPM) is a serious neurological disease of horses in Americans. Most cases are attributed to infection of the central nervous system with Sarcocystis neurona. Parasitemia has not been demonstrated in immunocompetent horses, but has been documented in one immunocompromised foal. The objective of this study was to isolate viable S. neurona from the blood of immunocompetent horses. Horses used in this study received orally administered S. neurona sporocysts (strain SN 37-R) daily for 112 days at the following doses: 100/day for 28 days, followed by 500/day for 28 days, followed by 1000/day for 56 days. On day 98 of the study, six yearling colts were selected for attempted culture of S. neurona from blood, two testing positive, two testing suspect and two testing negative for antibodies against S. neurona on day 84 of the study. Two 10 ml tubes with EDTA were filled from each horse by jugular venipuncture and the plasma fraction rich in mononuclear cells was pipetted onto confluent equine dermal cell cultures. The cultures were monitored weekly for parasite growth for 12 weeks. Merozoites grown from cultures were harvested and tested using S. neurona-specific PCR with RFLP to confirm species identity. PCR products were sequenced and compared to known strains of S. neurona. After 38 days of in vitro incubation, one cell culture from a horse testing positive for antibodies against S. neurona was positive for parasite growth while the five remaining cultures remained negative for parasite growth for all 12 weeks. The Sarcocystis isolate recovered from cell culture was confirmed to be S. neurona by PCR with RFLP. Gene sequence analysis revealed that the isolate was identical to the challenge strain SN-37R and differed from two known strains UCD1 and MIH1. To our knowledge this is the first report of parasitemia with S. neurona in an immunocompetent horse.